205 related articles for article (PubMed ID: 36269382)
21. [
Hu K; Wang L; Wu H; Huang S; Tian Y; Wang Q; Xiao C; Han Y; Tang G
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2833-2843. PubMed ID: 34893920
[TBL] [Abstract][Full Text] [Related]
22. [
Ji H; Song X; Lv X; Shao F; Long Y; Song Y; Song W; Qiao P; Gai Y; Jiang D; Lan X
Pharmaceuticals (Basel); 2024 Jun; 17(6):. PubMed ID: 38931393
[TBL] [Abstract][Full Text] [Related]
23. Head-to-Head Comparison of [
Wegen S; van Heek L; Linde P; Claus K; Akuamoa-Boateng D; Baues C; Sharma SJ; Schomäcker K; Fischer T; Roth KS; Klußmann JP; Marnitz S; Drzezga A; Kobe C
Mol Imaging Biol; 2022 Dec; 24(6):986-994. PubMed ID: 35771317
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of
Zhao L; Niu B; Fang J; Pang Y; Li S; Xie C; Sun L; Zhang X; Guo Z; Lin Q; Chen H
J Nucl Med; 2022 Jun; 63(6):862-868. PubMed ID: 34556528
[TBL] [Abstract][Full Text] [Related]
25. Detecting Fibroblast Activation Proteins in Lymphoma Using
Jin X; Wei M; Wang S; Wang G; Lai Y; Shi Y; Zhang Y; Yang Z; Wang X
J Nucl Med; 2022 Feb; 63(2):212-217. PubMed ID: 34049984
[TBL] [Abstract][Full Text] [Related]
26. Noninvasive Assessment of Renal Fibrosis of Chronic Kidney Disease in Rats by [
Mao H; Chen L; Wu W; Zhang L; Li X; Chen Y; Huang Z; Ou S
Mol Pharm; 2023 May; 20(5):2714-2725. PubMed ID: 37010328
[TBL] [Abstract][Full Text] [Related]
27. Feasibility of
Wang X; Guo Y; Gao Y; Ren C; Huang Z; Liu B; Li X; Chang L; Shen K; Ding H; Zhang H; Tian Z; Hacker M; Zhang S; Wang Y; Li J; Li X; Huo L
JACC Cardiovasc Imaging; 2022 Nov; 15(11):1960-1970. PubMed ID: 36357138
[TBL] [Abstract][Full Text] [Related]
28. Repetitive Early
Glatting FM; Hoppner J; Liew DP; van Genabith A; Spektor AM; Steinbach L; Hubert A; Kratochwil C; Giesel FL; Dendl K; Rathke H; Kauczor HU; Huber PE; Haberkorn U; Röhrich M
J Nucl Med; 2022 Dec; 63(12):1844-1851. PubMed ID: 35618480
[No Abstract] [Full Text] [Related]
29. Design, Preclinical Evaluation, and Clinical Translation of
Zhao L; Pang Y; Fang J; Chen J; Zhou Y; Sun L; Wu H; Guo Z; Lin Q; Chen H
J Nucl Med; 2024 Mar; 65(3):394-401. PubMed ID: 38176714
[TBL] [Abstract][Full Text] [Related]
30. Preclinical Evaluation and a Pilot Clinical Positron Emission Tomography Imaging Study of [
Du X; Gu B; Wang X; Wang X; Ji M; Zhang J; He S; Xu X; Yang Z; Song S
Mol Pharm; 2024 Feb; 21(2):904-915. PubMed ID: 38179677
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of preoperative [
Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Huo L; Li X
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1780-1791. PubMed ID: 36695823
[TBL] [Abstract][Full Text] [Related]
32. [
Zheng J; Liu F; Lin K; Zhang L; Huang N; Zheng W; Zhang J; Yao S; Miao W
Mol Imaging Biol; 2022 Dec; 24(6):973-985. PubMed ID: 35945360
[TBL] [Abstract][Full Text] [Related]
33. Noninvasive imaging of FAP expression using positron emission tomography: A comparative evaluation of a [
Huang J; Fu L; Zhang X; Huang S; Dong Y; Hu K; Han Y; Zhou K; Min C; Huang Y; Tang G
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3363-3374. PubMed ID: 37266596
[TBL] [Abstract][Full Text] [Related]
34. Improved cancer detection in Waldeyer's tonsillar ring by
Serfling S; Zhi Y; Schirbel A; Lindner T; Meyer T; Gerhard-Hartmann E; Lapa C; Hagen R; Hackenberg S; Buck AK; Scherzad A
Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1178-1187. PubMed ID: 33057927
[TBL] [Abstract][Full Text] [Related]
35. Superior Tumor Detection for
Pabst KM; Trajkovic-Arsic M; Cheung PFY; Ballke S; Steiger K; Bartel T; Schaarschmidt BM; Milosevic A; Seifert R; Nader M; Kessler L; Siveke JT; Lueckerath K; Kasper S; Herrmann K; Hirmas N; Schmidt HH; Hamacher R; Fendler WP
J Nucl Med; 2023 Jul; 64(7):1049-1055. PubMed ID: 37024301
[TBL] [Abstract][Full Text] [Related]
36. Clinical utility of [
Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
[TBL] [Abstract][Full Text] [Related]
37. Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy.
Zhao L; Chen J; Pang Y; Fang J; Fu K; Meng L; Zhang X; Guo Z; Wu H; Sun L; Su G; Lin Q; Chen H
Mol Pharm; 2022 Oct; 19(10):3640-3651. PubMed ID: 35917335
[TBL] [Abstract][Full Text] [Related]
38. Dual targeting PET tracer [
Wang R; Jakobsson V; Wang J; Zhao T; Peng X; Li B; Xue J; Liang N; Zhu Z; Chen X; Zhang J
Theranostics; 2023; 13(9):2979-2992. PubMed ID: 37284441
[No Abstract] [Full Text] [Related]
39. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
[TBL] [Abstract][Full Text] [Related]
40. Head-to-head Intra-individual Comparison of [
Novruzov E; Dendl K; Ndlovu H; Choyke PL; Dabir M; Beu M; Novruzov F; Mehdi E; Guliyev F; Koerber SA; Lawal I; Niegisch G; Debus J; Haberkorn U; Sathekge M; Giesel FL
Mol Imaging Biol; 2022 Aug; 24(4):651-658. PubMed ID: 35349039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]